[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Stocks Set to Open Higher as Oil Sinks on U.S.-Iran Deal Hopes, Jobs Data and Earnings Awaited

September S&P 500 E-Mini futures (ESU26) are up +0.57%, and September Nasdaq 100 E-Mini futures (NQU26) are up +0.47% this morning, pointing to a higher open on Wall Street as oil prices sank after U.S. President Donald Trump revived hopes for a deal to ease tensions in the Middle East.

The price of WTI crude slumped more than -6% on Monday after U.S. President Donald Trump abandoned plans to strike Iran and said new U.S.-Iran talks would begin. President Trump late Saturday called off a strike on Iran, saying on social media that Iran and other Middle Eastern countries had asked the...

Fundamentals

See More
  • Market Capitalization, $K 142,543,088
  • Shares Outstanding, K 5,699,444
  • Annual Sales, $ 62,579 M
  • Annual Income, $ 7,771 M
  • EBIT $ 19,384 M
  • EBITDA $ 25,976 M
  • 60-Month Beta 0.35
  • Price/Sales 2.27
  • Price/Cash Flow 5.67
  • Price/Book 1.57

Options Overview Details

View History
  • Implied Volatility 24.37% (-0.37%)
  • Historical Volatility 21.89%
  • IV Percentile 53%
  • IV Rank 38.50%
  • IV High 34.15% on 10/10/25
  • IV Low 18.25% on 08/18/25
  • Expected Move (DTE 3) 0.65 (2.61%)
  • Put/Call Vol Ratio 0.87
  • Today's Volume 169,302
  • Volume Avg (30-Day) 99,280
  • Put/Call OI Ratio 0.82
  • Today's Open Interest 2,447,042
  • Open Int (30-Day) 2,459,940
  • Expected Range 24.38 to 25.68

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.68
  • Number of Estimates 5
  • High Estimate $0.69
  • Low Estimate $0.66
  • Prior Year $0.78
  • Growth Rate Est. (year over year) -12.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.62 +5.97%
on 07/06/26
25.65 -2.42%
on 07/17/26
+0.71 (+2.92%)
since 07/02/26
3-Month
23.62 +5.97%
on 07/06/26
26.75 -6.43%
on 05/05/26
-1.30 (-4.94%)
since 05/01/26
52-Week
23.40 +6.97%
on 08/04/25
28.75 -12.92%
on 04/02/26
+1.54 (+6.56%)
since 08/01/25

Most Recent Stories

More News
Stocks Set to Open Higher as Oil Sinks on U.S.-Iran Deal Hopes, Jobs Data and Earnings Awaited

September S&P 500 E-Mini futures (ESU26) are up +0.57%, and September Nasdaq 100 E-Mini futures (NQU26) are up +0.47% this morning, pointing to a higher open on Wall Street as oil prices sank after U.S....

GOOGL : 373.51 (+4.88%)
UAL : 128.39 (+5.82%)
AAPL : 303.42 (-1.78%)
SNDK : 1,288.03 (+6.03%)
NQU26 : 29,076.75 (+0.64%)
PFE : 25.03 (+0.08%)
SHOP : 117.01 (-0.12%)
MSFT : 487.65 (+4.93%)
TSLA : 322.08 (+3.49%)
FERG : 250.08 (+6.72%)
WDC : 527.22 (-3.23%)
ESU26 : 7,637.50 (+0.12%)
Pfizer (PFE) Q2 Earnings: What To Expect

Pfizer (PFE) Q2 Earnings: What To Expect

PFE : 25.03 (+0.08%)
Earnings, PMI and Other Key Things to Watch this Week

Markets enter an earnings-dominated week with a huge concentration of corporate results spanning technology, industrials, healthcare, consumer discretionary, and entertainment sectors. This will provide...

APP : 406.16 (+2.59%)
ANET : 184.89 (+2.52%)
SPOT : 486.33 (-2.72%)
SNDK : 1,288.03 (+6.03%)
MRK : 127.77 (-1.87%)
PFE : 25.03 (+0.08%)
MCD : 265.23 (-2.00%)
DIS : 98.14 (+2.03%)
SHOP : 117.01 (-0.12%)
SPCX : 114.53 (+5.68%)
CAT : 830.03 (+1.87%)
AMD : 484.64 (+1.78%)
Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Two pivotal studies of LITFULO™ (ritlecitinib) in nonsegmental vitiligo met their co-primary endpoints, showing significant improvement in facial and total repigmentation versus placebo at Week 52 ...

PFE : 25.03 (+0.08%)
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

Data indicate that the 2026-2027 COVID-19 vaccine formula, targeting the XFG variant, induces a strong immune response against contemporary circulating and emerging lineages ...

PFE : 25.03 (+0.08%)
BNTX : 92.25 (+1.84%)
Is Wall Street Bullish or Bearish on Pfizer Stock?

While Pfizer has trailed the broader market over the past year, Wall Street still sees room for upside and remains moderately optimistic about the company's prospects.

$SPX : 7,600.50 (+1.48%)
PJP : 121.70 (+0.21%)
PFE : 25.03 (+0.08%)
FDA Grants Priority Review for Pfizer’s TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Supplemental application aims to expand use to men with HRR gene-mutated metastatic castration-sensitive prostate cancer Filing supported by Phase 3 TALAPRO-3...

PFE : 25.03 (+0.08%)
1 Stock Under $50 to Target This Week and 2 We Question

1 Stock Under $50 to Target This Week and 2 We Question

ULH : 18.21 (+36.10%)
PMT : 9.44 (+0.11%)
PFE : 25.03 (+0.08%)
Here's What to Expect From Pfizer's Next Earnings Report

Pfizer is set to announce its second-quarter earnings next month, and Wall Street expects a double-digit decline in its profit.

XLV : 162.24 (-0.19%)
$SPX : 7,600.50 (+1.48%)
PFE : 25.03 (+0.08%)
The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions

Wainua missed its Phase 3 endpoint, hitting Ionis Pharmaceuticals hard while AstraZeneca absorbed the blow easily, boosting rivals BridgeBio, Pfizer and Alnylam Pharmaceuticals.

AZN : 157.97 (-6.88%)
ALNY : 220.33 (+7.21%)
IONS : 54.49 (+5.25%)
BBIO : 79.96 (-0.16%)
PFE : 25.03 (+0.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 25.85
2nd Resistance Point 25.62
1st Resistance Point 25.33
Last Price 25.03
1st Support Level 24.80
2nd Support Level 24.57
3rd Support Level 24.28

See More

52-Week High 28.75
Fibonacci 61.8% 26.70
Fibonacci 50% 26.07
Fibonacci 38.2% 25.44
Last Price 25.03
52-Week Low 23.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.